PLUS THERAPEUTICS, INC. Quarterly Preferred Stock, Shares Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
Summary
Plus Therapeutics, Inc. quarterly Preferred Stock, Shares Issued history and growth rate from Q4 2010 to Q3 2024.
  • Plus Therapeutics, Inc. Preferred Stock, Shares Issued for the quarter ending September 30, 2024 was 1.95K shares, unchanged year-over-year.
Preferred Stock, Shares Issued, Quarterly (shares)
Preferred Stock, Shares Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.95K 0 0% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 1.95K 0 0% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 1.95K -1 -0.05% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.95K 0 0% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 1.95K 0 0% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 1.95K 0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 1.95K +1 +0.05% Mar 31, 2023 10-Q 2023-04-20
Q4 2022 1.95K 0 0% Dec 31, 2022 10-K 2024-03-05
Q3 2022 1.95K 0 0% Sep 30, 2022 10-Q 2022-10-20
Q2 2022 1.95K 0 0% Jun 30, 2022 10-Q 2022-07-21
Q1 2022 1.95K 0 0% Mar 31, 2022 10-Q 2022-04-21
Q4 2021 1.95K -2 -0.1% Dec 31, 2021 10-K 2023-02-23
Q3 2021 1.95K -2 -0.1% Sep 30, 2021 10-Q 2021-10-21
Q2 2021 1.95K -7 -0.36% Jun 30, 2021 10-Q 2021-07-22
Q1 2021 1.95K -7 -0.36% Mar 31, 2021 10-Q 2021-04-22
Q4 2020 1.95K -5 -0.26% Dec 31, 2020 10-K 2022-02-24
Q3 2020 1.95K -5 -0.26% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 1.96K -28.3K -93.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 1.96K -28.3K -93.5% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 1.96K -2.65K -57.5% Dec 31, 2019 10-K 2021-02-22
Q3 2019 1.96K -21.5K -91.7% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 30.2K +6.73K +28.7% Jun 30, 2019 10-Q 2019-08-15
Q1 2019 30.2K +6.72K +28.6% Mar 31, 2019 8-K 2019-09-10
Q4 2018 4.61K -25.6K -84.8% Dec 31, 2018 10-K 2020-03-30
Q3 2018 23.5K +10K +74.1% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 23.5K +10K +74.1% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 23.5K +10K +74.1% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 30.2K +6.72K +28.6% Dec 31, 2017 8-K 2019-09-10
Q3 2017 13.5K 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 13.5K Jun 30, 2017 10-Q 2017-08-11
Q1 2017 13.5K Mar 31, 2017 10-Q 2017-05-12
Q4 2016 23.5K +10K +74.1% Dec 31, 2016 10-K 2018-03-09
Q3 2016 13.5K Sep 30, 2016 10-Q 2016-11-09
Q4 2015 13.5K 0 0% Dec 31, 2015 10-K 2017-03-24
Q4 2014 13.5K +13.5K Dec 31, 2014 10-K 2015-03-16
Q3 2014 0 0 Sep 30, 2014 10-Q 2014-11-07
Q2 2014 0 0 Jun 30, 2014 10-Q 2014-08-11
Q1 2014 0 0 Mar 31, 2014 10-Q 2014-05-12
Q4 2013 0 0 Dec 31, 2013 10-K 2015-03-16
Q3 2013 0 0 Sep 30, 2013 10-Q 2013-11-12
Q2 2013 0 0 Jun 30, 2013 10-Q 2013-08-09
Q1 2013 0 0 Mar 31, 2013 10-Q 2013-05-10
Q4 2012 0 0 Dec 31, 2012 10-K 2014-03-14
Q3 2012 0 0 Sep 30, 2012 10-Q 2012-11-09
Q2 2012 0 0 Jun 30, 2012 10-Q 2012-08-09
Q1 2012 0 Mar 31, 2012 10-Q 2012-05-10
Q4 2011 0 0 Dec 31, 2011 10-K 2013-03-15
Q3 2011 0 Sep 30, 2011 10-Q 2011-11-08
Q2 2011 0 Jun 30, 2011 10-Q 2011-08-09
Q4 2010 0 Dec 31, 2010 10-K/A 2012-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.